MBNL1 and intrahepatic cholangiocarcinoma: To determine the effect of (CAG)7 ASO treatment on MBNL1 distribution, four independent expansion-positive CEC lines (Table S8) were selected and ICC was performed, following treatment with either the (CAG)7 or control ASO.